Back to Directory
Anamorelin
Metabolic & Weight ManagementGhrelin receptor agonist for cancer cachexia, stimulates appetite and anabolic effects.
Key Benefits
- ✓Stimulates appetite in cancer patients
- ✓Increases lean body mass
- ✓Treats cachexia
- ✓Anabolic effects
- ✓Improves quality of life
Dosing Information
Dosage Range
50-100 mg
Frequency
Once daily
Typical Duration
Ongoing during cancer treatment
Detailed Protocol
Taken orally once daily. Approved in Japan, investigational elsewhere. Prescription medication where approved.
About Anamorelin
Anamorelin is a selective ghrelin receptor agonist developed for cancer-related cachexia and anorexia. It stimulates appetite and has anabolic effects through GH release. Approved in Japan for cancer cachexia, investigational in other countries.
Research Notes
Approved in Japan in 2021 for cancer cachexia. Phase 3 trials showed increased lean body mass and improved appetite in cancer patients. Not FDA-approved.
Potential Side Effects
- •Hyperglycemia
- •Nausea
- •Fatigue
- •Diarrhea
- •Decreased appetite paradoxically in some
Always consult with a healthcare professional before starting any peptide therapy.